Acute hepatitis induced by Camellia sinensis (green tea) [1];Hepatits aguda inducida por Camellia sinensis (té verde)

Anales de Medicina Interna

Volumn 22, Issue 6, 2005, Pages 298-

  Abu El Wafa, Y ^a   Benavente Fernandez A ^a   Talavera Fabuel, A ^a   Perez Ramos M A ^a   Ramos Clemente, J I ^a  

^a HOSPITAL INFANTA ELENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CAMELLIA SINENSIS EXTRACT; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; FEMALE; HERBAL MEDICINE; HUMAN; LETTER; LIVER TOXICITY; OBESITY; TEA; TOXIC HEPATITIS; TREATMENT OUTCOME;

ADULT; CAMELLIA SINENSIS; FEMALE; HEPATITIS, TOXIC; HUMANS; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 23644454233     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Chanatre P, Lairon D. Recent findings of gree tea extract AR25(Exolise) and its actvity for the treatment of obesity. Phytomedicine 2002; 9: 3-8.
2. Seddik M, Lucidarme D, Creusy C, Filoche B. Is exolise® hepatotoxic? Gastroenterol Clin Biol 2001; 25: 834-5.
3. Pedrós C, Cereza G, García N, Laporte JR. Hepatotoxicidad por extracto etanólico seco de Camellia sinenesis. Med Clin (Barc) 2003; 121: 598-9.
4. Nota informativa de la Agencia Española del Medicamento: Suspensión de la comercialización de la especialidad farmaceútica Exolise®. Ref: 2003/03.
5. Aithal G, Rawlins M, Day C. Clinical diagnostic sacle: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-952.
6. Vasco AJ, Maria and Rui MM, Victorino. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-669.